RS55656B1 - Populacija matičnih ćelija humanog cerviksa uterusa i njene upotrebe - Google Patents

Populacija matičnih ćelija humanog cerviksa uterusa i njene upotrebe

Info

Publication number
RS55656B1
RS55656B1 RS20170164A RSP20170164A RS55656B1 RS 55656 B1 RS55656 B1 RS 55656B1 RS 20170164 A RS20170164 A RS 20170164A RS P20170164 A RSP20170164 A RS P20170164A RS 55656 B1 RS55656 B1 RS 55656B1
Authority
RS
Serbia
Prior art keywords
stem cell
cell population
human uterine
uterine cervical
cervical stem
Prior art date
Application number
RS20170164A
Other languages
English (en)
Inventor
Piñeiro Francisco José Vizoso
Fernández Román Pérez
Díaz Noemí Eiró
Original Assignee
Gistem Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gistem Res S L filed Critical Gistem Res S L
Publication of RS55656B1 publication Critical patent/RS55656B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/03—Coculture with; Conditioned medium produced by non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RS20170164A 2013-02-22 2013-02-22 Populacija matičnih ćelija humanog cerviksa uterusa i njene upotrebe RS55656B1 (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13156348.8A EP2770050B1 (en) 2013-02-22 2013-02-22 Human uterine cervical stem cell population and uses thereof

Publications (1)

Publication Number Publication Date
RS55656B1 true RS55656B1 (sr) 2017-06-30

Family

ID=47749687

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170164A RS55656B1 (sr) 2013-02-22 2013-02-22 Populacija matičnih ćelija humanog cerviksa uterusa i njene upotrebe

Country Status (26)

Country Link
US (2) US20160000835A1 (sr)
EP (1) EP2770050B1 (sr)
JP (1) JP6453771B2 (sr)
KR (1) KR102175493B1 (sr)
CN (1) CN105008520B (sr)
AU (1) AU2014220647B2 (sr)
BR (1) BR112015020001A2 (sr)
CA (1) CA2901505C (sr)
CY (1) CY1118704T1 (sr)
DK (1) DK2770050T3 (sr)
ES (1) ES2615824T3 (sr)
HK (1) HK1214300A1 (sr)
HR (1) HRP20170216T1 (sr)
HU (1) HUE030796T2 (sr)
IL (1) IL240573B (sr)
LT (1) LT2770050T (sr)
MX (1) MX2015010708A (sr)
NZ (1) NZ712583A (sr)
PL (1) PL2770050T3 (sr)
PT (1) PT2770050T (sr)
RS (1) RS55656B1 (sr)
RU (1) RU2679500C2 (sr)
SI (1) SI2770050T1 (sr)
SM (1) SMT201700114B (sr)
WO (1) WO2014128291A1 (sr)
ZA (1) ZA201506818B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044421A1 (en) * 2014-09-18 2016-03-24 National Health Research Institutes Progenitor cells, method for preparation thereof and uses thereof
KR20180012223A (ko) * 2016-07-25 2018-02-05 고려대학교 산학협력단 자궁 유래 성체줄기세포 분리 및 제조 방법
GB2571668B (en) * 2017-02-16 2023-02-22 Oct Therapies And Res Private Limited Stem cell conditioned media for clinical and cosmetic applications
CN108865973A (zh) * 2018-06-20 2018-11-23 广西医科大学第附属医院 Sd大鼠胃窦间质细胞的分离和培养方法
WO2021226373A2 (en) * 2020-05-08 2021-11-11 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
CN112057471B (zh) * 2020-09-11 2023-12-22 复旦大学附属妇产科医院 间充质干细胞的制药用途
CN112618712A (zh) * 2021-01-21 2021-04-09 武汉轻工大学 一种含波形蛋白的佐剂及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558570A1 (en) * 2009-10-08 2013-02-20 Fundacion Para La Investigacion De Celulas Madre Uterinas (Ficemu) Myometrial-derived mesenchymal stem cells and uses thereof
CN102229911B (zh) * 2011-06-08 2013-09-18 山西医科大学 Sca-1+/CD34－子宫干细胞及其分离方法
RU2481585C1 (ru) * 2011-11-09 2013-05-10 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГБУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ дифференциальной диагностики лейомиосарком и пролиферирующих (клеточных) лейомиом матки

Also Published As

Publication number Publication date
PL2770050T3 (pl) 2017-06-30
LT2770050T (lt) 2017-04-10
MX2015010708A (es) 2016-06-21
HUE030796T2 (en) 2017-06-28
NZ712583A (en) 2020-05-29
RU2015139970A (ru) 2017-03-30
KR20150133722A (ko) 2015-11-30
US20160000835A1 (en) 2016-01-07
CN105008520B (zh) 2020-10-30
HK1214300A1 (zh) 2016-07-22
WO2014128291A1 (en) 2014-08-28
HRP20170216T1 (hr) 2017-04-21
EP2770050A1 (en) 2014-08-27
RU2679500C2 (ru) 2019-02-11
IL240573B (en) 2020-01-30
AU2014220647A1 (en) 2015-10-08
US20210299184A1 (en) 2021-09-30
BR112015020001A2 (pt) 2018-02-20
SI2770050T1 (sl) 2017-06-30
AU2014220647B2 (en) 2019-06-27
PT2770050T (pt) 2017-02-21
JP2016509834A (ja) 2016-04-04
IL240573A0 (en) 2015-09-24
SMT201700114B (it) 2017-03-08
EP2770050B1 (en) 2016-11-16
ZA201506818B (en) 2020-02-26
DK2770050T3 (en) 2017-02-20
CA2901505A1 (en) 2014-08-28
ES2615824T3 (es) 2017-06-08
CA2901505C (en) 2021-06-08
CN105008520A (zh) 2015-10-28
KR102175493B1 (ko) 2020-11-09
CY1118704T1 (el) 2017-07-12
JP6453771B2 (ja) 2019-01-16

Similar Documents

Publication Publication Date Title
HK1214300A1 (zh) 人類子宮頸幹細胞群及其應用
HUE034927T2 (hu) Szilícium gél kompozíció és ennek alkalmazása
HK1216833A1 (zh) 組織擴張器、移植物及使用方法
HK1217964A1 (zh) 墊子狀成型體及其應用
HK1224171A1 (zh) 移動輔助裝置和相關聯的方法
HK1218561A1 (zh) 成體心臟幹細胞群
IL274995B (en) Stem cells extracted from brown fat and their use
IL240145A0 (en) Growth matrices for in vitro stem cell proliferation and tissue regeneration
IL245272B (en) pif-transfected cells and methods of use
SG11201510209SA (en) Cell populations, methods of transdifferention and methods of use thereof
SG11201603273PA (en) Methods and devices for soft tissue dissection
EP2964165A4 (en) DEVICES AND METHODS FOR UTERINE COMPRESSION
EP2853591A4 (en) HEMATOMIC HEMAZONE CELL LINE HLCZ01 AND USES THEREOF
EP2994007A4 (en) DEVICE FOR PUTTING HAIR INTO PLACE AND PROCEDURE FOR USE THEREOF
SG11202004529XA (en) Transformed human cell and use thereof
GB201316333D0 (en) Surgical device and methods
HK1218716A1 (zh) 包含泡騰片及護膚水的化妝套件
HRP20190041T1 (hr) Usatci za poticanje integriranja mekog i tvrdog tkiva
EP3184052A4 (en) Cell collection pad for examining cervical diseases and collection kit comprising same
EP2970883A4 (en) IMPROVED PLACENTAL STEM CELLS AND USES THEREOF
ZA201600724B (en) Stem canker tolerant soybeans and methods of use
EP2992087A4 (en) IDENTIFICATION AND ISOLATION OF ENDOTHELIAL CELLS OF THE HUMAN CORNEA (HCEC)
HK1205000A1 (en) Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20- spirox-4-en-3-one systems, intrauterine systems containing 18-methyl- 15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy 18--1516--19--20--4--3- 18--1516--19--20--4--3-
AU2013904175A0 (en) Stem cell line and use thereof